Akselband, Y. et al. (Dec. 1991). "Rapamycin Inhibits Spontaneous and Fibroblast Growth Factor Beta-Stimulated Proliferation of Endothelial Cells and Fibroblasts," Transplantation Proceedings 23(6):2833-2836.
Alteheld, A. et al. (2005). "Biodegradable Amorphous Copolyester-
Urefhane Networks Having Shape-Memory Properties,"
Angewandte Chemie International Edition 44:1188-1192.
Aramoto, H. et al. (Oct. 2004). "Vascular Endothelial Growth Factor
Stimulates Differential Signaling Pathways in In Vivo Microcircula-
tion," American Journal of Physiology—Heart and Circulatory
Physiology 287:H1590-H1598.
Auricchio, A. et al. (Aug. 2002). "Pharmacological Regulation of
Protein Expression from Adeno-Assoicated Viral Vectors in the Eye,"
Molecular Therapy 6(2):238-242.
Bainbridge, J. W. B. et al. (2003). "Hypoxia-Regulated Transgene Expression in Experimental Retinal Choroidal Neovascularization," Gene Therapy 10:1049-1054.
Beeley, N. R. F. et al. (Mar. 15, 2006). "Development, Implantation, In Vivo Elution, and Retrieval of a Biocompatible, Sustained Release Subretinal Drug Delivery System." Journal of Biomedical Materials Research Part A 76A:690-698.
Behl, C. (Dec. 1997). "Amyloid Beta-Protein Toxicity and Oxidative Stress in Alzheimer's Disease," Cell & Tissue Research 290(3):471480.
Bergers, G. et al. (Jun. 2003). "Tumorigenesis and the Angiogenic Switch," Nature Reviews-Cancer 3(6):401-410.
Bourne, R. R. et al., (1998). "Epidemic Optic Neuropathy in Primary
School Children in Dar es Salaam, Tanzania," British Journal of
Ophthalmology 82:232-234.
Bucci, M. et al. (Dec. 2000). "In Vivo Delivery of the Caveolin-1
Scaffolding Domain Inhibits Nitric Oxide Synthesis and Reduces
Inflammation," Nature Medicine 6(12): 1362-1367.
Cancer Weekly Editors. (Jan. 14, 2003). "Cancer Therapy: Study of
Possible Anticancer Drug Reveals New Mechanism of Gene Regu-
lation," Cancer Weekly via NewsRx.com and NewsRx.net, 2 pages.
Arias, L. (2007). "Management of Diabetic Macular Edema with
Antiangiogenic Therapy," Expert Review of Ophthalmology 2(1):23-
26.
Averbukh, E. et al. (Feb. 2006). "Diabetic Macular Edema: Towards
Therapy Aimed at the Underlying Pathogenic Mechanisms," The
Israel Medical Association Journal 8:127-128.
Ciulla, T. A. et al. (Sep. 2003). "Diabetic Retinopathy and Diabetic
Macular Edema: Pathophysiology, Screening, and Novel Therapies,"
Diabetes Care 26(9):2653-2664.
Ciulla. T. A. et al. (Sep.-Oct. 1998). "Age-Related Macular Degeneration: A Review of Experimental Treatments," Survey of Ophthalmology 43(2): 134-146.
Lai, A. (1993). "Drop Volume of Commerical Anti-Glaucoma Eye Drops," Indian Journal of Pharmacology 25:163-164. Pavan-Langston, D. (1996). Manual of Ocular Diagnosis and Therapy. Fourth Edition, Little, Brown and Company: New York, pp. 162-165.
* cited by examiner
